Search

Now showing items 1-3 of 3

Pharmacokinetics of isoniazid, rifampin,and pyrazinamide in children younger than two years of age with tuberculosis: Evidence for implementation of revised World Health Organization recommendations

Thee S.; Seddon J.A.; Donald P.R.; Seifart H.I.; Werely C.J.; Hesseling A.C.; Rosenkranz B.; Roll S.; Magdorf K.; Schaaf H.S. (2011)

Abnormal thyroid function tests in children on ethionamide treatment

Thee S.; Zollner E.W.; Willemse M.; Hesseling A.C.; Magdorf K.; Schaaf H.S. (2011)

Ethionamide (ETH) treatment may cause hypothyroidism. Clinical data, serum thyroid stimulating hormone (TSH) and free thyroxine (fT4) levels were retrospectively assessed in 137 children receiving anti-tuberculosis treatment ...

Pharmacokinetics of ethionamide in children

Thee S.; Seifart H.I.; Rosenkranz B.; Hesseling A.C.; Magdorf K.; Donald P.R.; Schaaf H.S. (2011)

Ethionamide (ETH), a second-line antituberculosis drug, is frequently used in treating childhood tuberculosis. Data supporting ETH dose recommendations in children are limited. The aim of this study was to determine the ...

Search

Filters

Pharmacokinetics of isoniazid, rifampin,and pyrazinamide in children younger than two years of age with tuberculosis: Evidence for implementation of revised World Health Organization recommendations

Abnormal thyroid function tests in children on ethionamide treatment

Pharmacokinetics of ethionamide in children